These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 16618426)

  • 1. The changing face of colorectal cancer in inflammatory bowel disease: progress at last!
    Rubin DT
    Gastroenterology; 2006 Apr; 130(4):1350-2. PubMed ID: 16618426
    [No Abstract]   [Full Text] [Related]  

  • 2. [Inflammatory bowel disease and colorectal cancer].
    Hagymási K; Tulassay Z
    Orv Hetil; 2006 Oct; 147(41):1977-82. PubMed ID: 17120688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Colorectal cancer in idiopathic inflammatory bowel disease.
    Harpaz N; Talbot IC
    Semin Diagn Pathol; 1996 Nov; 13(4):339-57. PubMed ID: 8946611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surveillance of patients at increased risk of colon cancer: inflammatory bowel disease and other conditions.
    Konda A; Duffy MC
    Gastroenterol Clin North Am; 2008 Mar; 37(1):191-213, viii. PubMed ID: 18313546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Tracing colorectal carcinoma in patients with inflammatory bowel disease].
    de Jong DJ; Nagengast FM
    Ned Tijdschr Geneeskd; 2007 Dec; 151(50):2758-60. PubMed ID: 18232192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surveillance programmes for colorectal cancer in inflammatory bowel disease: have we got it right?
    Bernstein CN
    Gut; 2008 Sep; 57(9):1194-6. PubMed ID: 18719132
    [No Abstract]   [Full Text] [Related]  

  • 7. Inflammatory bowel disease-associated cancers: does gender change incidence?
    Ullman TA
    Gastroenterology; 2010 May; 138(5):1658-60. PubMed ID: 20332045
    [No Abstract]   [Full Text] [Related]  

  • 8. Risk factors for colorectal neoplasia in inflammatory bowel disease: a nested case-control study from Copenhagen county, Denmark and Olmsted county, Minnesota.
    Jess T; Loftus EV; Velayos FS; Winther KV; Tremaine WJ; Zinsmeister AR; Scott Harmsen W; Langholz E; Binder V; Munkholm P; Sandborn WJ
    Am J Gastroenterol; 2007 Apr; 102(4):829-36. PubMed ID: 17222314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognosis of inflammatory bowel disease across time and countries. An epidemiological study of population-based patient cohorts.
    Jess T
    Dan Med Bull; 2008 May; 55(2):103-20. PubMed ID: 19017498
    [No Abstract]   [Full Text] [Related]  

  • 10. Endoscopy/surveillance in inflammatory bowel disease.
    Ahmadi AA; Polyak S
    Surg Clin North Am; 2007 Jun; 87(3):743-62. PubMed ID: 17560423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical study of the relationship between inflammatory bowel diseases and colorectal neoplasms.
    Zhao YJ; Yuan YZ
    J Dig Dis; 2009 May; 10(2):113-7. PubMed ID: 19426393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cancer and inflammatory bowel diseases].
    Flourié B; Moussata D; Nancey S; Bonvoisin S; Benahmed M; Descos L
    Gastroenterol Clin Biol; 2003 Mar; 27(3 Suppl):S104-11. PubMed ID: 12704304
    [No Abstract]   [Full Text] [Related]  

  • 13. [Epidemiology and natural history of chronic inflammatory bowel disease].
    Lerebours E; Savoye G; Guedon C
    Gastroenterol Clin Biol; 2003 Mar; 27(3 Suppl):S76-80. PubMed ID: 12704299
    [No Abstract]   [Full Text] [Related]  

  • 14. Cancer surveillance in inflammatory bowel disease: new molecular approaches.
    Risques RA; Rabinovitch PS; Brentnall TA
    Curr Opin Gastroenterol; 2006 Jul; 22(4):382-90. PubMed ID: 16760754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AGA technical review on the diagnosis and management of colorectal neoplasia in inflammatory bowel disease.
    Farraye FA; Odze RD; Eaden J; Itzkowitz SH
    Gastroenterology; 2010 Feb; 138(2):746-74, 774.e1-4; quiz e12-3. PubMed ID: 20141809
    [No Abstract]   [Full Text] [Related]  

  • 16. Review article: The relevance of surveillance endoscopy in long-lasting inflammatory bowel disease.
    Vleggaar FP; Lutgens MW; Claessen MM
    Aliment Pharmacol Ther; 2007 Dec; 26 Suppl 2():47-52. PubMed ID: 18081648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AGA medical position statement on the diagnosis and management of colorectal neoplasia in inflammatory bowel disease.
    Farraye FA; Odze RD; Eaden J; Itzkowitz SH; McCabe RP; Dassopoulos T; Lewis JD; Ullman TA; James T; McLeod R; Burgart LJ; Allen J; Brill JV;
    Gastroenterology; 2010 Feb; 138(2):738-45. PubMed ID: 20141808
    [No Abstract]   [Full Text] [Related]  

  • 18. Review article: the effect of aminosalicylates and immunomodulation on cancer risk in inflammatory bowel disease.
    Stange EF
    Aliment Pharmacol Ther; 2006 Oct; 24 Suppl 3():64-7. PubMed ID: 16961748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Colorectal cancer and inflammatory bowel disease: epidemiology, risk factors, mechanisms of carcinogenesis and prevention strategies.
    Triantafillidis JK; Nasioulas G; Kosmidis PA
    Anticancer Res; 2009 Jul; 29(7):2727-37. PubMed ID: 19596953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neoplastic precursor lesions related to the development of cancer in inflammatory bowel disease.
    Harpaz N
    Gastroenterol Clin North Am; 2007 Dec; 36(4):901-26, vii-viii. PubMed ID: 17996797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.